玻璃体切除术治疗糖尿病性视网膜病变玻璃体积血

Vitrectomy in patients of diabetic vitreous hemorrhage

目的 探讨玻璃体切除术治疗糖尿病性视网膜病变后单纯性玻璃体积血的临床疗效。方法 回顾性分析 1 998年 8月～ 2 0 0 0年 1 0月我院采用玻璃体切除方法治疗糖尿病性视网膜病变单纯玻璃体积血患者 40例 (40眼 ) ,观察其临床疗效及术后并发症 ,随访期术后 3～ 1 2月。结果 所有患者均顺利完成玻璃体积血切割术 ,术后 3月视力≥ 0 6者 1 0眼 ,视力 0 1～0 6者 2 0眼 ,视力数指～0 1者 5眼 ,3眼术后发生视网膜脱离视力下降 ,2眼术后发生新生血管性青光眼 ,后行睫状体冷凝术视力丧失。结论 玻璃体切除术对于糖尿病性增生性视网膜病变所致的玻璃体积血性药物治疗长期不吸收的患者是安全有效的治疗方法 ,术后并发症少 。

To evaluate the efficacy of vitrectomy in patients of vitreous hemorrhage because of proliferative diabetic retinopathy (PDR).Methods Between 1998～2000,40 eyes of 40 patients with vitreou s hemorrhage because of diabetic retinopathy were treated with vitrectomy.The po stroperative complications and clinical effects were observed.The follow-up peri od was 3 months to 12 months.Results All of the cases were performed vitrectomy successfully .The best corrected visual acuity in 10 eyes were≥0 6,20 eyes were 0 1～0 6,5 eyes were CF～0 1.The other 5 eyes had poor visual acuity because of pos toperative complications(retinal detachment in 3 eyes,neovascular glaucoma in 2 eyes).Conclusion Vitrectomy is a safe,effective method to the patient s with vitreous hemorrhage for PDR.